Significant FDA approvals in 1999.
McGinnis
T J
TJ
Office of Policy, US Food and Drug Administration, Rockville, Maryland, USA.
D019380:Anti-HIV Agents / Q000627:therapeutic use; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use; D017277:Drug Approval; D006505:Hepatitis / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007155:Immunologic Factors / Q000627:therapeutic use; D007251:Influenza, Human / Q000188:drug therapy; D008193:Lyme Disease / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D019440:Anti-Obesity Agents; D000970:Antineoplastic Agents; D002317:Cardiovascular Agents; D007004:Hypoglycemic Agents; D007155:Immunologic Factors